Literature DB >> 1519673

Helicobacter pylori. Its role in the pathogenesis of peptic ulcer disease in a new animal model.

J S Ross1, H X Bui, A del Rosario, H Sonbati, M George, C Y Lee.   

Abstract

The association and causative role of Helicobacter pylori infection of the stomach with gastric ulcer, duodenal ulcer, non-ulcer dyspepsia, and gastritis has remained controversial. The authors studied the effects of daily intragastric administration of H. pylori suspension in saline (10(8) CFU/ml) and bacteria-free filtrates of saline H. pylori suspensions in 85 Sprague-Dawley rats (weight, 150 to 200 g) with normal mucosa and with surgically produced experimental gastric ulcers. Group I rats (n = 30) with pre-existent experimental gastric ulcers received H. pylori suspension (ATCC 43504, 10(8) CFU/ml); Group II rats (n = 20) with experimental gastric ulcers received bacteria-free H. pylori filtrates; Group III rats with ulcers (n = 20) received saline alone; and Group IV control rats (n = 15) without ulcers received intact H. pylori organisms in suspension (ATCC 43504, 10(8) CFU/ml). At death, ulcer surface areas were measured with a dissecting microscope. Full-thickness sections were obtained for quantitative and qualitative histologic parameters, including the area of remaining mucosal necrosis; characteristics and cellular composition of restored mucosal architectures; and presence or absence of inflammation including counts of neutrophils and lymphocytes. H. pylori organisms were identified within the surface mucus and crypts using routine, special, and immunohistochemical stains. Our results indicate that the continued presence of either intact H. pylori organisms or bacteria-free H. pylori filtrates in the stomachs of rats with pre-existent gastric ulcers resulted in delayed healing of the ulcers and persistence of chronic active inflammation. Daily administration of suspensions of H. pylori organisms to sham-operated rats with intact gastric mucosa, however, resulted in no ulceration or inflammation despite identification of surface H. pylori organisms at death. The authors conclude that H. pylori alone causes little or no effect on an intact gastric mucosa in the rat, that either intact organisms or bacteria-free filtrates cause similar prolongation and delayed healing of pre-existing ulcers with active chronic inflammation, and that the presence of predisposing factors leading to disruption of gastric mucosal integrity may be required for the H. pylori enhancement of inflammation and tissue damage in the stomach.

Entities:  

Mesh:

Year:  1992        PMID: 1519673      PMCID: PMC1886702     

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  34 in total

Review 1.  Campylobacter pyloridis, gastritis, and peptic ulceration.

Authors:  C S Goodwin; J A Armstrong; B J Marshall
Journal:  J Clin Pathol       Date:  1986-04       Impact factor: 3.411

2.  Demonstration of a cytotoxin from Campylobacter pylori.

Authors:  V Hupertz; S Czinn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1988-08       Impact factor: 3.267

3.  Naturally occurring chronic gastritis and C pylori infection in the rhesus monkey: a potential model for gastritis in man.

Authors:  A Baskerville; D G Newell
Journal:  Gut       Date:  1988-04       Impact factor: 23.059

4.  Helicobacter mustelae-associated gastritis in ferrets. An animal model of Helicobacter pylori gastritis in humans.

Authors:  J G Fox; P Correa; N S Taylor; A Lee; G Otto; J C Murphy; R Rose
Journal:  Gastroenterology       Date:  1990-08       Impact factor: 22.682

5.  Location of peptic ulcers in relation to antral and fundal gastritis by chromoendoscopic follow-up examinations.

Authors:  M Tatsuta; H Iishi; S Okuda
Journal:  Dig Dis Sci       Date:  1986-01       Impact factor: 3.199

Review 6.  Gastric Campylobacter-like organisms, gastritis, and peptic ulcer disease.

Authors:  M J Blaser
Journal:  Gastroenterology       Date:  1987-08       Impact factor: 22.682

7.  Ingestion of Campylobacter pyloridis causes gastritis and raised fasting gastric pH.

Authors:  A Morris; G Nicholson
Journal:  Am J Gastroenterol       Date:  1987-03       Impact factor: 10.864

8.  Campylobacter pylori and recurrence of duodenal ulcers--a 12-month follow-up study.

Authors:  J G Coghlan; D Gilligan; H Humphries; D McKenna; C Dooley; E Sweeney; C Keane; C O'Morain
Journal:  Lancet       Date:  1987-11-14       Impact factor: 79.321

Review 9.  Campylobacter pylori and peptic ulcer disease.

Authors:  D Y Graham
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

10.  Cytotoxic activity in broth-culture filtrates of Campylobacter pylori.

Authors:  R D Leunk; P T Johnson; B C David; W G Kraft; D R Morgan
Journal:  J Med Microbiol       Date:  1988-06       Impact factor: 2.472

View more
  9 in total

1.  Effects of genotypically different strains of Helicobacter pylori on human microvascular endothelial cells in vitro.

Authors:  N Kalia; C Jones; D K Bardhan; M W Reed; J C Atherton; N J Brown
Journal:  Dig Dis Sci       Date:  2001-01       Impact factor: 3.199

Review 2.  Oxidative stress in Helicobacter pylori-induced gastric cell injury.

Authors:  Hyeyoung Kim
Journal:  Inflammopharmacology       Date:  2005       Impact factor: 4.473

Review 3.  Is there a role for psychology in ulcer disease?

Authors:  R Murison
Journal:  Integr Physiol Behav Sci       Date:  2001 Jan-Mar

4.  Antigastric autoantibodies in Helicobacter pylori infection: implications of histological and clinical parameters of gastritis.

Authors:  G Faller; H Steininger; J Kränzlein; H Maul; T Kerkau; J Hensen; E G Hahn; T Kirchner
Journal:  Gut       Date:  1997-11       Impact factor: 23.059

5.  Helicobacter pylori down-regulates the receptors of vascular endothelial growth factor and angiopoietin in vascular endothelial cells: implications in the impairment of gastric ulcer healing.

Authors:  Joo Sung Kim; Jung Mogg Kim; Hyun Chae Jung; In Sung Song
Journal:  Dig Dis Sci       Date:  2004-05       Impact factor: 3.199

6.  Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease.

Authors:  P Ghiara; M Marchetti; M J Blaser; M K Tummuru; T L Cover; E D Segal; L S Tompkins; R Rappuoli
Journal:  Infect Immun       Date:  1995-10       Impact factor: 3.441

7.  Simple animal model of Helicobacter pylori infection.

Authors:  Duangporn Werawatganon
Journal:  World J Gastroenterol       Date:  2014-06-07       Impact factor: 5.742

8.  Establishment of Noninvasive Methods for the Detection of Helicobacter pylori in Mongolian Gerbils and Application of Main Laboratory Gerbil Populations in China.

Authors:  Xiulin Zhang; Cunlong Wang; Yang He; Jin Xing; Yan He; Xueyun Huo; Rui Fu; Xuancheng Lu; Xin Liu; Jianyi Lv; Xiaoyan Du; Zhenwen Chen; Changlong Li
Journal:  Biomed Res Int       Date:  2022-03-29       Impact factor: 3.411

9.  Lung tumor motion change during stereotactic body radiotherapy (SBRT): an evaluation using MRI.

Authors:  Anneyuko I Saito; Kenneth R Olivier; Jonathan G Li; Chihray Liu; Heather E Newlin; Ilona Schmalfuss; Shinsuke Kyogoku; James F Dempsey
Journal:  J Appl Clin Med Phys       Date:  2014-05-08       Impact factor: 2.102

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.